NIH award NIH awarded $314K (STTR Phase I 1R41AI197509-01, new, notice Sep 8, 2026); 2 NIH awards totaling $1.29M in the last 12 months; 5 roles open. NIH RePORTER 1R41AI197509-01 (Sep 8, 2026)Evidence (2 events)
Sep 8, 2026 · NIH RePORTER 1R41AI197509-01 Organization: INBIOS INTERNATIONAL, INC.; City/State: Seattle, WA; Project number: 1R41AI197509-01; Activity code: R41; Fiscal year: 2026; Award notice date: 2026-09-08; FY total cost (award amount): 314363; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Development of a sensitive Point-of-Care immunoassay for tick- borne spotted fever group rickettsioses; Organization type: Domestic For-Profits
Jun 11, 2026 · NIH RePORTER 5R44AI184032-03 Organization: INBIOS INTERNATIONAL, INC.; City/State: Seattle, WA; Project number: 5R44AI184032-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-11; FY total cost (award amount): 974356; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease; Organization type: Domestic For-Profits
Grant Government grant — STTR: $314,363 (annual award, as published), announced Sep 8, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Grant Government grant — SBIR: $974,356 (annual award, as published), announced Jun 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
FDA FDA 510(k) clearance: COVID-19 Detect Rapid Self -Test — K251595, Oct 12, 2025. Applicant at approval: InBios International, Inc. source ↗
Grant Government grant — SBIR: $988,977 (annual award, as published), announced May 8, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Trial start —: Prospective Clinical Evaluation of COVID/Flu Detect™ Rapid Self-Test in Symptomatic Subjects for Non-Prescription Over-the-Counter (OTC) Use source ↗
Trial start —: Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI) source ↗
Trial start —: Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA source ↗
Trial start —: Specificity Study of Diagnostic for Chagas Disease source ↗
Trial start —: Sensitivity Study of Diagnostic for Detection of Chagas Infection source ↗
Trial start —: Specificity Study of Diagnostic for Early Detection of Dengue Infection source ↗
Trial start —: Sensitivity Study of Diagnostic for Early Detection of Dengue Infection source ↗
Funding
Last 2 years.
Government grant — STTR: $314,363 (annual award, as published), announced Sep 8, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Government grant — SBIR: $974,356 (annual award, as published), announced Jun 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Government grant — SBIR: $988,977 (annual award, as published), announced May 8, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Sensitivity Study of Diagnostic for Detection of Chagas Infection
Not listed
Completed
2013-06
2015-09 (actual)
FDA records (last 2 years)
FDA 510(k) clearance: COVID-19 Detect Rapid Self -Test — K251595, Oct 12, 2025. Applicant at approval: InBios International, Inc. source ↗
NIH awards 27
Annual award amounts. Total $10.6M.
NIH award 1R44AI184032-01 FY2024: $999,997 awarded for that fiscal year; activity R44 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Development of Next-gen Chagas D source ↗
NIH contract (government contract; not a grant and not an investment round) 75N91024C00078-0-9999-1 FY2024: $399,866 awarded for that fiscal year; activity N43 (OTHER_NIH); PI RATCHAUDHURI, SYAMAL; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. source ↗
NIH award 5R41AI149940-02 FY2021: $298,935 awarded for that fiscal year; activity R41 (STTR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Point-of-care antigen detection source ↗
NIH contract (government contract; not a grant and not an investment round) 75N93021C00063-0-9999-1 FY2021: $299,584 awarded for that fiscal year; activity N43 (OTHER_NIH); PI RAYCHAUDHURI, SYAMAL; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. source ↗
NIH award 1R41AI149940-01 FY2020: $299,112 awarded for that fiscal year; activity R41 (STTR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Point-of-care antigen detection source ↗
NIH award 5R42AI102482-05 FY2016: $700,138 awarded for that fiscal year; activity R42 (STTR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Antigen Detection assay for the source ↗
NIH award 5R42AI102482-04 FY2015: $673,521 awarded for that fiscal year; activity R42 (STTR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Antigen Detection assay for the Diagn source ↗
NIH award 2R42AI102482-03 FY2014: $621,080 awarded for that fiscal year; activity R42 (STTR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Antigen Detection assay for the Diagn source ↗
NIH award 5R41AI102482-02 FY2013: $299,699 awarded for that fiscal year; activity R41 (STTR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Antigen Detection Assay for the Diagn source ↗
NIH award 1R43DK096713-01 FY2012: $182,430 awarded for that fiscal year; activity R43 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Sensitive and Specific Rapid Dia source ↗
NIH award 1R41AI102482-01 FY2012: $299,699 awarded for that fiscal year; activity R41 (STTR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Antigen Detection Assay for the Diagn source ↗
NIH award 5R44AI052683-05 FY2010: $459,198 awarded for that fiscal year; activity R44 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Geographically robust rapid assa source ↗
NIH award 2R44AI052683-04 FY2009: $530,883 awarded for that fiscal year; activity R44 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Geographically robust rapid assa source ↗
NIH award 5R43AI074172-02 FY2008: $309,725 awarded for that fiscal year; activity R43 (SBIR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., Seattle, WA. Rapid antigen detection test for Deng source ↗
NIH award 5R43AI068166-02 FY2007: $278,818 awarded for that fiscal year; activity R43 (SBIR); PI MORROW, WILLIAM JOHN W.; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Development of rapid detection source ↗
NIH award 1R43AI074172-01 FY2007: $375,019 awarded for that fiscal year; activity R43 (SBIR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Rapid antigen detection test for Deng source ↗
NIH award 1R41AI068291-01A1 FY2006: $386,997 awarded for that fiscal year; activity R41 (STTR); PI CAMPOS-NETO, ANTONIO; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Antigen Detection Assay for Tube source ↗
NIH award 1R43AI068166-01A1 FY2006: $329,004 awarded for that fiscal year; activity R43 (SBIR); PI MORROW, WILLIAM JOHN W.; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Development of rapid detectio source ↗
NIH award 5R43AI066647-02 FY2006: $541,271 awarded for that fiscal year; activity R43 (SBIR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Development of rapid detection tests source ↗
NIH award 1R43AI066647-01 FY2005: $465,727 awarded for that fiscal year; activity R43 (SBIR); PI HOUGHTON, RAYMOND; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Development of rapid detection tests source ↗
NIH award 5R44AI052683-03 FY2005: $381,820 awarded for that fiscal year; activity R44 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Geographically robust rapid assa source ↗
NIH award 2R44AI052683-02 FY2004: $470,363 awarded for that fiscal year; activity R44 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. Geographically robust rapid assa source ↗
NIH award 5R44AI047551-03 FY2002: $346,969 awarded for that fiscal year; activity R44 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. New Generation Test for Visceral source ↗
NIH award 1R43AI052683-01 FY2002: $99,812 awarded for that fiscal year; activity R43 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. A Novel, Rapid Test for Diagnosis source ↗
NIH award 2R44AI047551-02 FY2001: $391,863 awarded for that fiscal year; activity R44 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. New Generation Test for Visceral source ↗
NIH award 1R43AI046850-01 FY2000: $99,938 awarded for that fiscal year; activity R43 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. A NOVEL IMMUNOCHROMATOGRAPHIC DIA source ↗
NIH award 1R43AI047551-01 FY2000: $98,994 awarded for that fiscal year; activity R43 (SBIR); PI RAYCHAUDHURI, SYAMAL X; recipient as written: INBIOS INTERNATIONAL, INC., SEATTLE, WA. NEXT GENERATION ASSAY FOR THE DIA source ↗
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
